EP300 and glioblastoma: Along with the observation in Figure 6M that neither p53 depletion nor re‐expression affected Smad1 acetylation in GBM cells, it demonstrates that Smad1 and p53 compete for p300 mediated acetylation, while Smad1 has the priority over p53 (Figure 6L).